Unity Biotechnology Files 8-K
| Field | Detail |
|---|---|
| Company | Unity Biotechnology, Inc. |
| Form Type | 8-K |
| Filed Date | Mar 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, 8-K
TL;DR
Unity Biotech filed an 8-K on 3/24/25. Standard corporate update.
AI Summary
Unity Biotechnology, Inc. filed an 8-K on March 24, 2025, reporting other events and financial statements. The company, formerly known as Cenexys, Inc. and Forge Inc., is incorporated in Delaware and headquartered in South San Francisco, California.
Why It Matters
This filing provides an update on Unity Biotechnology's corporate activities and financial reporting, which is important for investors to track the company's status.
Risk Assessment
Risk Level: low — This is a routine corporate filing with no immediate material financial or operational changes indicated.
Key Numbers
- 001-38470 — Commission File Number (Identifies the company's SEC filing history.)
- 26-4726035 — IRS Employer Identification Number (Tax identification number for the company.)
Key Players & Entities
- Unity Biotechnology, Inc. (company) — Registrant
- Cenexys, Inc. (company) — Former Company Name
- Forge Inc (company) — Former Company Name
- 285 East Grand Avenue (location) — Principal Executive Offices Address
- South San Francisco, CA 94080 (location) — Principal Executive Offices City, State, Zip
- March 24, 2025 (date) — Date of Report
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of March 24, 2025.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on March 24, 2025.
What are the former names of Unity Biotechnology, Inc. mentioned in the filing?
The filing mentions that Unity Biotechnology, Inc. was formerly known as Cenexys, Inc. and Forge Inc.
Where are Unity Biotechnology, Inc.'s principal executive offices located?
Unity Biotechnology, Inc.'s principal executive offices are located at 285 East Grand Ave., South San Francisco, CA 94080.
What is the Commission File Number for Unity Biotechnology, Inc.?
The Commission File Number for Unity Biotechnology, Inc. is 001-38470.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 24, 2025 regarding Unity Biotechnology, Inc..